From: Treatment of primary headache in children: a multicenter hospital-based study in France
Original treatment, n (%) | Revised treatment, n (%) | Change | |
---|---|---|---|
Acute headache treatments | |||
NSAIDS | 175 (55.9) | 202 (64.5) | 1.15 |
Paracetamol | 260 (83.1) | 66 (21.1) | 0.25 |
Ergot alkaloid | 5 (1.6) | 3 (1.0) | 0.60 |
Triptan | 9 (2.9) | 58 (18.5) | 6.44 |
Analgesics | 4 (1.3) | None | – |
None | 16 (5.1) | 43 (13.7) | 2.69 |
Prophylactic treatments | |||
Antiserotonergics | 13 (4.2) | 28 (9.0) | 2.15 |
Tricyclics | 1 (0.3) | 8 (2.6) | 8.00 |
Beta blockers | 1 (0.3) | 5 (1.6) | 5.00 |
Ca channel blockers | 4 (1.3) | 7 (2.2) | 1.75 |
Ergot alkaloids | 25 (8.0) | 14 (4.5) | 0.56 |
Antiepileptic drugs | 2 (0.6) | 2 (0.6) | 1.00 |
No prophylaxis | 279 (89.1) | 249 (79.6) | 0.89 |
Non-pharmacological treatments | |||
Psychotherapy | 7 (2.2) | 33 (10.5) | 4.71 |
Relaxation | 2 (0.6) | 43 (13.7) | 21.50 |
Biofeedback | None | 8 (2.6) | – |